JP2009543885A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009543885A5 JP2009543885A5 JP2009520962A JP2009520962A JP2009543885A5 JP 2009543885 A5 JP2009543885 A5 JP 2009543885A5 JP 2009520962 A JP2009520962 A JP 2009520962A JP 2009520962 A JP2009520962 A JP 2009520962A JP 2009543885 A5 JP2009543885 A5 JP 2009543885A5
- Authority
- JP
- Japan
- Prior art keywords
- dosage form
- ibuprofen
- famotidine
- unit dosage
- oral
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11/489,269 US20080021078A1 (en) | 2006-07-18 | 2006-07-18 | Methods and medicaments for administration of ibuprofen |
| US11/489,272 US20080020040A1 (en) | 2006-07-18 | 2006-07-18 | Unit dose form for administration of ibuprofen |
| US89737107P | 2007-01-24 | 2007-01-24 | |
| PCT/US2007/073716 WO2008011426A2 (en) | 2006-07-18 | 2007-07-17 | Methods and medicaments for administration of ibuprofen |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2009543885A JP2009543885A (ja) | 2009-12-10 |
| JP2009543885A5 true JP2009543885A5 (enExample) | 2011-08-11 |
Family
ID=38957561
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009520962A Pending JP2009543885A (ja) | 2006-07-18 | 2007-07-17 | イブプロフェンの投与のための方法および医薬 |
Country Status (13)
| Country | Link |
|---|---|
| EP (2) | EP2438919A1 (enExample) |
| JP (1) | JP2009543885A (enExample) |
| AT (1) | ATE539747T1 (enExample) |
| AU (1) | AU2007275360B2 (enExample) |
| BR (1) | BRPI0714937A2 (enExample) |
| CA (1) | CA2657928C (enExample) |
| DK (1) | DK2043637T3 (enExample) |
| ES (1) | ES2380747T3 (enExample) |
| IL (1) | IL196425A (enExample) |
| NZ (1) | NZ574200A (enExample) |
| PL (1) | PL2043637T3 (enExample) |
| PT (1) | PT2043637E (enExample) |
| WO (1) | WO2008011426A2 (enExample) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8067451B2 (en) | 2006-07-18 | 2011-11-29 | Horizon Pharma Usa, Inc. | Methods and medicaments for administration of ibuprofen |
| US8067033B2 (en) | 2007-11-30 | 2011-11-29 | Horizon Pharma Usa, Inc. | Stable compositions of famotidine and ibuprofen |
| WO2008091957A2 (en) * | 2007-01-24 | 2008-07-31 | Horizon Therapeutics, Inc. | Pharmaceutical compositions containing famotidine and ibuprofen and having improved content uniformity |
| WO2013054352A1 (en) | 2011-08-17 | 2013-04-18 | Cadila Healthcare Limited | Pharmaceutical compositions of ibuprofen and famotidine |
| PT2912193T (pt) | 2012-10-29 | 2018-11-29 | Arizona Board Of Regents On Behalf Of Univ Of Arizona | Marcadores preditivos para terapêuticas de cancro de inibidor de poliamina |
| WO2015163832A1 (en) | 2014-04-25 | 2015-10-29 | Pharmacti̇ve İlaç Sanayi̇ Ve Ti̇caret A.Ş. | An ibuprofen and famotidine combined composition having improved stability |
| JP2017519770A (ja) | 2014-06-18 | 2017-07-20 | アリゾナ ボード オブ リージェンツ オン ビハーフ オブ ザ ユニバーシティ オブ アリゾナ | Ｏｄｃ１遺伝子型に基づく癌腫の診断および処置 |
| WO2016130918A1 (en) | 2015-02-12 | 2016-08-18 | The Arizona Board Of Regents On Behalf Of The University Of Arizona | Methods for treating neuroblastoma |
| WO2017075576A1 (en) * | 2015-10-30 | 2017-05-04 | Cancer Prevention Pharmaceuticals, Inc. | Eflornithine and sulindac, fixed dose combination formulation |
| CA3003149C (en) | 2015-10-30 | 2023-10-31 | Cancer Prevention Pharmaceuticals, Inc. | Eflornithine and sulindac, fixed dose combination formulation |
| WO2020236562A1 (en) | 2019-05-17 | 2020-11-26 | Cancer Prevention Pharmaceuticals, Inc. | Methods for treating familial adenomatous polyposis |
| CA3124579C (en) | 2020-07-15 | 2026-03-31 | Schabar Research Associates Llc | Unit oral dose compositions composed of naproxen sodium and famotidine for the treatment of acute pain and the reduction of the severity of heartburn and/or the risk of heartburn |
| JP2023534810A (ja) * | 2020-07-15 | 2023-08-14 | シャバー リサーチ アソシエイツ エルエルシー | 急性痛の処置並びに胸やけの重症度及び／又はリスクの低減のための、イブプロフェン及びファモチジンから構成される単位経口用量組成物 |
| US12514846B2 (en) | 2020-07-15 | 2026-01-06 | Schabar Research Associates Llc | Unit oral dose compositions composed of ibuprofen or a pharmaceutically acceptable salt thereof and famotidine or a pharmaceutically acceptable salt thereof for the treatment of acute pain and the reduction of the severity and/or risk of heartburn and/or upset stomach |
| JP2024514989A (ja) * | 2021-10-21 | 2024-04-03 | ハン ファ ファーマ カンパニー、リミテッド | モンテルカストまたはその薬学的に許容可能な塩、及びレボセチリジンまたはその薬学的に許容可能な塩を含有する、安定性が改善されたフィルムコーティング錠剤 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6056143B2 (ja) | 1979-08-02 | 1985-12-09 | 山之内製薬株式会社 | アミジン誘導体ならびにその製造法 |
| US4543370A (en) | 1979-11-29 | 1985-09-24 | Colorcon, Inc. | Dry edible film coating composition, method and coating form |
| US4802924A (en) | 1986-06-19 | 1989-02-07 | Colorcon, Inc. | Coatings based on polydextrose for aqueous film coating of pharmaceutical food and confectionary products |
| HU196775B (en) | 1986-08-05 | 1989-01-30 | Richter Gedeon Vegyeszet | Process for production of morfologically unique new modifications of famotidin and medical compositions containing such substances |
| EP0663839A4 (en) * | 1992-09-29 | 1998-06-03 | Merck & Co Inc | Ibuprofen-h 2? antagonist combinations. |
| US5976578A (en) * | 1996-10-10 | 1999-11-02 | Mcneil-Ppc, Inc. | Liquid antacid compositions |
| US6251945B1 (en) | 1999-01-14 | 2001-06-26 | Knoll Aktiengesellschaft | Pharmaceutical mixture comprising a combination of a profen and other active compounds |
| DE10003757A1 (de) | 2000-01-28 | 2001-08-02 | Knoll Ag | Ibuprofen-Wirkstoffzubereitung |
| EP1411900B2 (en) * | 2001-06-01 | 2013-12-04 | Pozen, Inc. | PHARMACEUTICAL COMPOSITIONS FOR THE COORDINATED DELIVERY OF NSAIDs |
| DE10153934A1 (de) | 2001-11-06 | 2003-05-22 | Basf Ag | Verfahren zur Kristallisation von Profenen |
| WO2004064815A1 (en) * | 2003-01-21 | 2004-08-05 | Smartrix Technologies Inc. | Oral dosage formulation |
| JP2006076956A (ja) * | 2004-09-10 | 2006-03-23 | Taiyo Yakuhin Kogyo Kk | 胃炎の治療・予防用配合剤 |
| CA2615496C (en) * | 2005-07-18 | 2014-11-18 | Horizon Therapeutics, Inc. | Medicaments containing famotidine and ibuprofen and administration of same |
| DE102005049001A1 (de) | 2005-10-11 | 2007-04-12 | Basf Ag | Verfahren zur Herstellung von direkttablettierbaren Ibuprofen-Formulierungen |
-
2007
- 2007-07-17 EP EP12150096A patent/EP2438919A1/en not_active Withdrawn
- 2007-07-17 ES ES07813027T patent/ES2380747T3/es active Active
- 2007-07-17 AT AT07813027T patent/ATE539747T1/de active
- 2007-07-17 JP JP2009520962A patent/JP2009543885A/ja active Pending
- 2007-07-17 WO PCT/US2007/073716 patent/WO2008011426A2/en not_active Ceased
- 2007-07-17 DK DK07813027.5T patent/DK2043637T3/da active
- 2007-07-17 BR BRPI0714937-9A patent/BRPI0714937A2/pt not_active Application Discontinuation
- 2007-07-17 PL PL07813027T patent/PL2043637T3/pl unknown
- 2007-07-17 NZ NZ574200A patent/NZ574200A/en not_active IP Right Cessation
- 2007-07-17 CA CA2657928A patent/CA2657928C/en not_active Expired - Fee Related
- 2007-07-17 AU AU2007275360A patent/AU2007275360B2/en not_active Ceased
- 2007-07-17 EP EP07813027A patent/EP2043637B8/en not_active Not-in-force
- 2007-07-17 PT PT07813027T patent/PT2043637E/pt unknown
-
2009
- 2009-01-11 IL IL196425A patent/IL196425A/en active IP Right Grant
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2006504795A5 (enExample) | ||
| JP2022180461A5 (enExample) | ||
| JP2021066744A5 (ja) | ブプロピオンおよびデキストロメトルファンを含む組成物 | |
| JP2009536147A5 (enExample) | ||
| JP2010525050A5 (enExample) | ||
| JP2013231087A5 (enExample) | ||
| TWI455723B (zh) | 納曲酮及安非他酮於治療超重或肥胖病患之用途 | |
| JP2012031131A5 (enExample) | ||
| JP2009501801A5 (enExample) | ||
| HRP20130057T1 (hr) | Lijeäśenje progresivne neurodegenerativne bolesti ibudilastom | |
| JP2012515184A5 (enExample) | ||
| Bhaskar et al. | Comparison of transdermal diclofenac patch with oral diclofenac as an analgesic modality following multiple premolar extractions in orthodontic patients: a cross over efficacy trial | |
| JP2011527301A5 (enExample) | ||
| JP2019517542A5 (enExample) | ||
| CA2570474A1 (en) | A combination composition comprising paracetamol and ibuprofen | |
| JP2013541583A5 (enExample) | ||
| JP2013544290A5 (enExample) | ||
| JP2012533559A5 (enExample) | ||
| JP2016530291A5 (enExample) | ||
| AR105184A1 (es) | Comprimidos de liberación inmediata que contienen un fármaco y procesos para formar los comprimidos | |
| JP2005068010A5 (enExample) | ||
| HRP20161470T1 (hr) | Smjese flurbiprofena s kontroliranim otpuštanjem i mišićnog relaksanta | |
| JP2005517040A5 (enExample) | ||
| BR0013719A (pt) | Dosagem oral de liberaçâo controlada, apropriada para administração oral | |
| JP2012505830A5 (enExample) |